2333 GMT - A2 Milk's product recall in the U.S. could reverberate elsewhere. The company is recalling three batches of infant milk formula products sold in the U.S. due to the presence of cereulide. Analyst Jonathan Snape suggests a2 Milk could need to step up brand investment in China to reassure customers there about product safety. "The timing of the recall is also less than ideal as a2 Milk is already short product on ground in China and hence already needed to potentially invest to recapture customers that had switched to alternative suppliers," Bell Potter says. It retains a hold call on a2 Milk and cuts its price target by 19% to A$6.75/share. On the ASX, a2 Milk's shares ended Monday at A$6.55. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
May 04, 2026 19:33 ET (23:33 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments